Tirzepatide (GLP1 plus GIP drug) cut the chances of transitioning from pre-diabetes to diabetes by over 90%.
Insulin resistance may be an adaptive response to nutrient excess
Louis discusses a Cell Metabolism paper proposing insulin resistance and T2D as allostatic responses to chronic nutrient excess. He notes glucose-only drugs (sulfonylureas, insulin) don't improve outcomes consistently while metformin, SGLT2i and GLP-1 agonists do.



